Evidence map›Paper›PMID 33677868›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2021

[Clinical features and prognosis of ETV6-RUNX1-positive childhood B-precursor acute lymphocyte leukemia].

Y Z Zheng, L L Pan, J Li, Z S Chen, X L Hua, S H Le, H Zheng, C Chen, J D Hu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Y Z ZhengDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
L L PanDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
J LiDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Z S ChenDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
X L HuaDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
S H LeDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
H ZhengDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
C ChenDepartment of Pediatric Hematology, Fujian Medical University Union Hospital, Fuzhou 350001, China.
J D HuDepartment of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory, Fujian Medical University Union Hospital, Fuzhou 350001, China.
Fujian Medical University · CN

Funding

Construction Project of Fujian Medical Center of Hematology Min201704Startup Fund for scientific research, Fujian Medical University 2019QH1032Young and Middle-aged Scientist Fundation of Fujian Provincial Health Commission 2018-ZQN-26
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Core Binding Factor Alpha 2 SubunitLymphocytesChildChinaDisease-Free SurvivalHumansOncogene Proteins, FusionPrognosisRetrospective StudiesCore Binding Factor Alpha 2 SubunitOncogene Proteins, FusionRUNX1 protein, humanChildETV6-RUNX1 fusion geneLeukemia, lymphoblastic, acutePrognosis

Identifiers

PMID33677868
PMCPMC7957247
OpenAlexW3133865522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.